Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients

Circulation

Volumn 94, Issue 12, 1996, Pages 3115-3122

  Antony, Isabelle ^a,b   Lerebours, Guy ^a   Nitenberg, Alain ^a  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

arteries; endothelium; enzymes; hypertension; tests

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRILAT;

ADULT; ARTICLE; CLINICAL ARTICLE; COLD PRESSOR TEST; CORONARY ARTERY; CORONARY VASCULAR RESISTANCE; DRUG EFFECT; DRUG SCREENING; FEMALE; HEART CATHETERIZATION; HUMAN; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; VASODILATATION;

EID: 0030482532     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3115     Document Type: Article

References (57)

1. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarisation of canine coronary smooth muscle. Br J Pharmacol. 1988; 93:515-524.
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K. Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988; 332:411-415.
4. Lüscher TF, Boulanger CM, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension. 1992;19:117-130.
5. De Chastonay C, Gabbiani G, Elemer G, Hüttner I. Remodeling of the rat aortic endothelial layer during experimental hypertension: changes in replication rate, cell density, and surface morphology. Lab Invest. 1983;48:45-52.
6. Lüscher TF, Diederich D, Weber E, Vanhoutte PM, Bühler FR. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension. 1988;11:573-578.
7. Tesfamariam B, Halpern W. Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension. 1988;11:440-444.
8. Brush JE, Faxon DP, Salmon S, Jacobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol. 1992;19:809-815.
9. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993; 87:86-93.
10. Drexler H, Zeiher AM, Wollschläger H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation. 1989;80:466-474.
11. Antony I, Lerebours G, Nitenberg A. Loss of flow-dependent coronary artery dilatation in patients with hypertension. Circulation. 1995;91:1624-1628.
12. Antony I, Aptecar E, Lerebours G, Nitenberg A. Coronary artery constriction caused by the cold pressor test in human hypertension. Hypertension. 1994;24:212-219.
13. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988;77:43-52.
14. Lindsey CJ, Bendhack LM, Paiva AC. Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity. J Hypertens. 1987;5(suppl):S71-S76.
15. Furchgott RF. Role of the endothelium in responses of vascular smooth muscle. Circ Res. 1983;53:557-573.
16. Nakashima M, Mombouli J-V, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 1993;92:2867-2871.
17. Mombouli J-V, Nephtali M, Vanhoutte PM. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension. 1991;18(suppl II):II-22-II-29.
18. Morganti A, Grassi G, Giannattasio C, Bolla GB, Turolo L, Saino A, Sala C, Mancia G, Zancnetti A. Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension. J Hypertens. 1989;7:825-835.
19. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system. J Hypertens. 1984;2:581-587.
20. Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM, Fish RD, Ganz P, Selwyn AP. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation. 1992;85:1390-1397.
21. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
22. Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation. 1986;73:444-451.
23. Robertson D, Johnson GA, Robertson RM, Nies AS, Shand DG, Gates JA. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation. 1979;59: 637-643.
24. Macho P, Hintze TH, Vatner SF. Regulation of large coronary arteries by increases in myocardial metabolic demands in conscious dogs. Circ Res. 1981;49:594-599.
25. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium derived relaxing factor. Am J Physiol. 1986;250:H1145-H1149.
26. Kuo J, Davis MJ, Chilian WM. Endothelium-dependent flow-induced dilation of isolated coronary arterioles. Am J Physiol. 1990;259: H1063-H1070.
27. Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol. 1989;14:1181-1190.
28. Xiang JZ, Schölkens BA, Ganten D, Unger T. Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor Hoe 498 in isolated rabbit hearts. Clin Exp Hypertens. 1984;A6: 1853-1857.
29. Collis MG, Keddie JR, Captopril attenuates adrenergic vasoconstriction in rat mesenteric arteries by angiotensin-dependent and -independent mechanisms. Clin Sci. 1981;61:281-286.
30. Perondi R, Saino A, Tio RA, Pomidossi G, Gregorini L, Alessio P, Morganti A, Zanchetti A, Mancia G. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation. 1992;85:2004-2013.
31. Magrini F, Reggiani P, Fratianni G, Morganti A, Zanchetti A. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension. J Cardiovasc Pharmacol 1992;19(suppl 5):S128-S133.
32. Magrini F, Shimizu M, Roberts N, Fouad FM, Tarazi RC, Zanchetti A. Converting enzyme inhibition and coronary blood flow. Circulation. 1987;75(suppl I):I-168-I-174.
33. Zeiher AM, Drexler H, Wollschläger H, Hanjörg J. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991;84:1984-1992.
34. Ueeda M, Silvia SK, Olsson RA. Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res. 1992;70:1296-1303.
35. Panza JA, Quyyumi AA, Brush JF, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
36. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
37. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
38. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
39. Treasure CB, Manoukian SV, Klein JL, Vita JA, Nabel EG, Renwick GH, Selwyn AP, Alexander RW, Ganz P. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 1992;71:776-781.
40. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med. 1994;330:1036-1040.
41. Lüscher TF, Vanhoutte PM, Raij L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension. 1987;9(suppl III):III-193-III-197.
42. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532-540.
43. Tschudi MR, Criscione L, Novosel D, Pfeiffer K, Lüscher TF. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation. 1994;89:2212-2218.
44. Shultz PJ, Raij L. Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations. Br J Clin Pharmacol. 1989;28:151S-157S.
45. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21:1145-1151.
46. Creager MA, Roddy M-A. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24: 499-505.
47. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshita A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension. 1992;20: 175-180.
48. Holtz J, Förstermann U, Pohl U, Giesler M, Bassenge E. Flow-dependent, endothelium-mediated dilatation of epicardial coronary arteries in conscious dogs: effects of cyclo-oxygenase inhibition. J Cardiovasc Pharmacol. 1984;6:1161-1169.
49. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
50. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314-1319.
51. Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, Kajiyama G. Flow-mediated vasodilation of human epieardial coronary arteries: effect of inhibition of nitric oxide synthesis. J Am Coll Cardiol. 1996;27:304-310.
52. Vanhoutte PM, Auch-Schwelk W, Biondi ML, Lorenz RR, Schini VB, Vidai MJ. Why are converting enzyme inhibitors vasodilators? Br J Clin Pharmacol. 1989;28:95S-104S.
53. Groves P, Kurz S, Just H, Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation. 1995;92:3424-3430.
54. Yang HY, Erdos EG, Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta. 1970;214:374-376.
55. Mombouli J-V, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in the canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 1992;71:137-144.
56. Foult JM, Tavolaro O, Antony I, Nitenberg A. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique. Circulation. 1988;77:337-344.
57. Sudhir K, Chou TM, Hutchison SJ, Chatterjee K. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo. Differential contribution of nitric oxide and bradykinin in conductance and resistance arteries. Circulation. 1996;93:1734-1739.